Scheving L E, Tsai T H, Pauly J E, Halberg F
Peptides. 1984 May-Jun;5(3):507-18. doi: 10.1016/0196-9781(84)90079-2.
The objective was to determine the effect of adrenocorticotropin (ACTH 1-17) on the incorporation of [3H]TdR into DNA (DNA synthesis) in the tongue, esophagus and stomach of CD2F1 mice standardized to 12 hours of light alternating with 12 hours of darkness. A question asked was whether the time of administration along the 24-hour time scale influenced any response found. The response was complex as ACTH 1-17 was capable of bringing about statistically significant increases in the incorporation of [3H]TdR into DNA at certain times, decreases at other times, or no response at still another time. In general the most marked effects of 20 IU/kg of ACTH 1-17 when compared to controls, was to decrease DNA synthesis of as much as 60% 4 hours after administration at the end of the dark or beginning of the light span. A 2- and 3-way analysis of variance supported the conclusion that the kind-of-treatment, time-of-treatment and the interval-to-kill (Sampling time) as well as their interactions are important factors when determining any response of ACTH 1-17 or placebo.
目的是确定促肾上腺皮质激素(ACTH 1-17)对标准化为12小时光照与12小时黑暗交替的CD2F1小鼠的舌、食管和胃中[3H]TdR掺入DNA(DNA合成)的影响。提出的一个问题是,在24小时时间尺度上的给药时间是否会影响所发现的任何反应。反应很复杂,因为ACTH 1-17在某些时间能够使[3H]TdR掺入DNA的量出现统计学上的显著增加,在其他时间减少,或在另外一些时间没有反应。一般来说,与对照组相比,20 IU/kg的ACTH 1-17最显著的作用是在黑暗期结束或光照期开始给药4小时后使DNA合成减少多达60%。双向和三向方差分析支持了以下结论:治疗类型、治疗时间、处死间隔(采样时间)及其相互作用是确定ACTH 1-17或安慰剂的任何反应时的重要因素。